Holen Sie sich die Stockscreener-App
5.43
2.16%
-0.12
Handel nachbörslich:
5.42
-0.010
-0.18%
Schlusskurs vom Vortag:
$5.55
Offen:
$5.24
24-Stunden-Volumen:
2.66M
Relative Volume:
1.40
Marktkapitalisierung:
$385.89M
Einnahmen:
$11.40B
Nettoeinkommen (Verlust:
$-95.73M
KGV:
-2.2163
EPS:
-2.45
Netto-Cashflow:
$-64.37M
1W Leistung:
-12.28%
1M Leistung:
-12.84%
6M Leistung:
-2.51%
1J Leistung:
-49.72%
1-Tages-Spanne:
$4.93
$5.55
1-Wochen-Bereich:
$4.93
$6.065
52-Wochen-Spanne:
$4.93
$11.36
Mind Medicine Inc Stock (MNMD) Company Profile
Firmenname
Mind Medicine Inc
Sektor
Branche
Telefon
212-220-6633
Adresse
ONE WORLD TRADE CENTER, NEW YORK
Vergleichen Sie MNMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
5.43 | 385.89M | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 65.79B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 35.18B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 32.67B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-28 | Eingeleitet | Evercore ISI | Outperform |
| 2024-12-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-10-14 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-07-24 | Eingeleitet | ROTH MKM | Buy |
| 2024-05-29 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-15 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-12-09 | Fortgesetzt | ROTH Capital | Buy |
| 2022-11-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-26 | Eingeleitet | Oppenheimer | Outperform |
| 2022-08-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-05-04 | Eingeleitet | ROTH Capital | Buy |
| 2021-06-28 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Mind Medicine Inc Aktie (MNMD) Neueste Nachrichten
Long Term Trading Analysis for (MNMD) - news.stocktradersdaily.com
MNMD stock touches 52-week low at $5.03 amid market challenges - Investing.com
Mind Medicine CEO Robert Barrow sells shares worth $142,941 By Investing.com - Investing.com Canada
MindMed Advances Clinical Programs with Strong Financial Backing - TipRanks
Mind Medicine CEO Robert Barrow sells shares worth $142,941 - Investing.com India
MindMed Announces New Employee Inducement Grants - Business Wire
MindMed Strengthens Brain Health Pipeline with Key Technical Talent Acquisition - Stock Titan
Generalized Anxiety Disorder Treatment Market Size in 7MM - openPR
MindMed appoints new Chief Commercial Officer By Investing.com - Investing.com South Africa
MindMed Appoints Matt Wiley as Chief Commercial Officer - Quantisnow
MindMed appoints new Chief Commercial Officer - Investing.com
MindMed Taps Former Jazz Pharma Executive to Lead MM120 Anxiety Drug Launch - Stock Titan
MindMed’s SWOT analysis: psychedelic stock’s journey through mental health market - Investing.com
MindMed at Leerink’s Global Healthcare Conference: Strategic Insights on Psychedelics - Investing.com India
What is HC Wainwright’s Estimate for MNMD FY2029 Earnings? - Defense World
Robert W. Baird Cuts Mind Medicine (MindMed) (NASDAQ:MNMD) Price Target to $16.00 - Defense World
Mind Medicine (MindMed)’s (MNMD) Buy Rating Reiterated at HC Wainwright - Defense World
Mind Medicine’s (MNMD) Recent Achievements Boosting Stock - Markets Insider
Rhumbline Advisers Buys 4,868 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Oppenheimer & Co. Inc. Grows Stock Holdings in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Sanctuary Advisors LLC Lowers Stock Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
H.C. Wainwright maintains MindMed stock Buy rating, $55 target - Investing.com India
Mind Medicine’s Promising Future: Buy Rating Backed by Strong Phase 3 Prospects and Financial Position - TipRanks
Mind Medicine Inc (MNMD) Q4 2024 Earnings Call Highlights: Strat - GuruFocus.com
Mind Medicine Inc (MNMD) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial ... - Yahoo Finance
MindMed Advances Clinical Trials and Strengthens Financial Position - TipRanks
Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months - MSN
MindMed posts strong cash position, progress on LSD treatment - Green Market Report
Earnings call transcript: MindMed misses Q4 2024 EPS forecast, stock slides - Investing.com
Mind Medicine (MindMed) Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Mind Medicine (MindMed) Inc. SEC 10-K Report - TradingView
Mind Medicine reports Q4 EPS (41c), consensus (28c) - TipRanks
MIND MEDICINE Earnings Results: $MNMD Reports Quarterly Earnings - Nasdaq
Mind Medicine (MindMed) Inc. Loss At -$34.74 Mln In Q4 - Nasdaq
MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates - Joplin Globe
MindMed to Present at Leerink’s Global Healthcare Conference 2025 - TipRanks
Can MindMed's Conference Appearance Signal New Brain Health Breakthroughs? - Stock Titan
Learn to Evaluate (MNMD) using the Charts - Stock Traders Daily
Mind Medicine (MindMed) Inc. (MNMD): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
12 Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
Mind Medicine (MindMed) (MNMD) Projected to Post Earnings on Thursday - MarketBeat
Mind Medicine (MindMed) (MNMD) Expected to Announce Quarterly Earnings on Thursday - Defense World
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 5.3%Here's Why - MarketBeat
When the Price of (MNMD) Talks, People Listen - Stock Traders Daily
Can MindMed's 2024 Financial Results Reveal Its Brain Health Pipeline Progress? - StockTitan
Mind Medicine (MindMed) (NASDAQ:MNMD) Stock Price Down 5.3%Time to Sell? - MarketBeat
Mind Medicine (MindMed) (MNMD) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Finanzdaten der Mind Medicine Inc-Aktie (MNMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mind Medicine Inc-Aktie (MNMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Karlin Daniel | Chief Medical Officer |
Mar 25 '25 |
Sale |
6.74 |
6,836 |
46,075 |
446,177 |
| Sullivan Mark | Chief Legal Officer |
Mar 25 '25 |
Sale |
6.74 |
6,576 |
44,322 |
316,621 |
| Liao Carrie | Chief Accounting Officer |
Mar 25 '25 |
Sale |
6.74 |
2,347 |
15,819 |
144,923 |
10.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):